 |
인쇄하기
취소
|
Dong-A targets W800 billion sales
Backed by active promotion of flagship products (e.g., Stillen, Zydena) and strenuous overseas expansion, Dong-A Pharm has set an ambitious goal of 800 billion won in sales and 100 billion in operating income this year.
The local top drugmaker said that the goal represents an 14 percent rise from 702.3 billion won in sales for last year.
“We will reach 1.4 trillion won in sales by 2012 t...
The local top drugmaker said that the goal represents an 14 percent rise from 702.3 billion won in sales for last year.
“We will reach 1.4 trillion won in sales by 2012 t...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.